Clinical Trials Directory

Trials / Completed

CompletedNCT02954705

MICRO-RNAs OF NEUTROPHILS IN RENAL ANTINEUTROPHIL CYTOPLASMIS ANTIBODY (ANCA) -ASSOCIATED VASCULITIS

MICRO-RNAs OF NEUTROPHILS IN RENAL ANCA-ASSOCIATED VASCULITIS

Status
Completed
Phase
Study type
Observational
Enrollment
63 (actual)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Activation of neutrophils by ANCA ("Anti-Neutrophil Cytoplasm Antibodies") and subsequent microvascular endothelial cell damage is the main feature of ANCA-associated vasculitis (AAV), a severe autoimmune disease that often targets the kidney. There is no specific treatment for AAV to date and 25% of patients with renal damage evolve towards end-stage renal disease, requiring dialysis and kidney transplantation. In addition, there is no reliable biological marker of the disease activity available, which makes the diagnostic, follow-up and treatment of patients difficult. Therefore, the identification of new therapeutic targets and non-invasive biomarkers constitutes a major clinical challenge to improve AAV patients care and to ameliorate their renal outcome.

Conditions

Interventions

TypeNameDescription
OTHERNon interventional studyThis is a non interventional study because all levies are performed during visit planned for the care of patients.

Timeline

Start date
2017-08-28
Primary completion
2019-12-31
Completion
2020-09-30
First posted
2016-11-03
Last updated
2020-10-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02954705. Inclusion in this directory is not an endorsement.